Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Can't do anything about the past so we march forward. So far multiple trial success's. I for one see a successful 2017 coming.
The 6 week efficacy peak under the prurisol hood come March/April will change the sentiment. I for one am ready for some early spring fireworks.
Thanks for your effort. I received the following response:
"Thank you for your support of Anavex Life Sciences Corp. (Nasdaq: AVXL).
I am writing to confirm receipt of your email and thank you for your comments, which have been noted for management.
Please do not hesitate to contact our office if we can be of further assistance".
I'm still hoping for post CTAD follow up PR which further outlines the great results found in the 12 month data.
Kinda sums it up prepared and pre-recorded, not sure if it was detrimental though, just more par for the course.. Hopefully next year a live call like the next multi-billion$$ company they want be.
Hey $1.49 looks like steal compared to some I own.
No real analyst view until after uplisting. For now ctix remains a retail speculative stock
Exactly love the recent news and the real life results to it.. Those who called it a scam are now very interested believe me.
yes and I think it's huge. There's a lot Fool followers.
Yep. They see the writing on the wall over there and are now getting onboard.
They have access to cash for the next couple years maybe even longer. Time is on our side for Leo to make a great deal.
Thank you for your honesty here. Phase 2/3 on deck. Funding news will be forthcoming.
No gap...ah nice to be king.
The wording from PR said they have funds to "prepare" for phase 2/3 AD, Parkinson and Retts syndrome in 2017. Dr Missling has said there would be a partnering for a large placebo controlled phase 2/3 Alzheimer's trial. I for one am waiting for the Biogen results.
I also believe you guys are on to something with the idea that A-273 sets to promote healing and regeneration of brain cells over time. A-273 is not just another drug that blows out the pipes so to speak.
I find the "THERAPEUTIC RESPONSE UNEXPECTED" on slide 30 impressive. I counted some 16 patients all with remarkable change of life anecdotal evidence. These folks are improving and getting on with a fuller life.
SGX942 study is IV 2x week after radiation treatment requiring clinician to dose. B-OM oral rinse will be a prescription that a patient could dose at home saving money.
Good post. Yes it all falls back on the data and not the price gyrations. I don't pay attention to the gap yappers.
I agree. But being it's a Saturday it won't matter market wise.
Thank You Boston. That makes perfect sense.
I'm not sure if there is a webcast. I was wondering if we could hear Dr Misslings oral presentation.
Where can I find a link to tomorrows webcast? TIA
I'll pass.
AIR001 now in 3 phase 2 trials. Positive outcome could result in a lucrative buyout next year. Current trials are already funded.
Anecdotal evidence: Pianist Pauline Stevens has regained the ability to play the piano after being placed on the experimental Anavex 2-73 drug trial at Caulfield Hospital.
Award-winning artist Valerie Lynch has also rediscovered the ability to paint after beginning the medication, stunning her doctors, family and friends.
https://www.google.com/#q=melbourne+au+anavex+273+piano+player
Arch Therapeutics to Present at 9th Annual LD Micro Main Event on December 7, 2016.
https://finance.yahoo.com/news/arch-therapeutics-present-9th-annual-230342924.html
News of expected partnership will go a long ways to stop the shorts.
Update at 41 weeks looks quite promising. Maybe a momentous December after all.<wink>
I think we got the news 11/22.. "At 41 weeks, Alzheimer’s patients taking a daily oral dose of ANAVEX 2-73 in the exploratory, not yet dose optimized Phase 2a clinical trial, showed a stabilization of cognitive and functional measures. This data of stabilization is promising since Alzheimer’s disease is a progressive disease where current therapeutics are only able to temporarily slow the worsening of dementia symptoms and not stop the disease from progressing."
Also this: George Perry, PhD, Dean and Professor at the University of Texas at San Antonio and Editor-in Chief of the Journal of Alzheimer’s Disease, commented, “Although this is an open label study with 32 patients, I have never seen mild-to-moderate Alzheimer’s patients maintain near baseline cognitive and activities of daily living function and positive correlation with all other measures over a 41-week trial period in any prior study with an approved or experimental drug. It is quite plausible that complex CNS diseases like Alzheimer’s may require a comprehensive approach, including restoration of cellular homeostasis.”
Yes thanks, got the PM also and yes great observation and thanks for posting.
Extension design was to provide continued access to A-273. Wording of A-273 as add-on therapy to SOC dropped.
Thanks for the reply. I do find it intriguing though not to see any mention of Donepezil combination at 41 weeks.
"Initially planned for 26 weeks, PART B was extended to 52 weeks as a result of requests from patients and caregivers". Are all patients taking A-273 in the extended trial? No mention of Donepezel in 41 week update.
No worries as current share price is not even close to present or future value. . 2017 the year of ctix.
Keep looking.
He loves to stand corrected. Well he's been corrected. lol
Much more going on here then Prurisol, could see $4 before March.
Thank you. The next update will be another huge vote of confidence for B not only for UP but also OM as a anti-inflamatory. Leo and company getting the business done..
News will move ctix stock. When can we expect the next UP update? TIA
Exactly. A non-toxic pill will bring in a hefty upfront payment. The best part about going into P phase2b is we know the stuff works good. This trial will show just how good.